
The Samsung scandal played a prominent role in this weeks’ top ten after the South Korean firm was delisted from …

South Korean firm Samsung BioLogics has been delisted from the South Korean stock exchange. The decision has come after the …

Business, biosimilars and Brexit are the themes of this week’s top 10. While Roche signed a $1 billion deal with …

American multinational MSD have won a $117 million contract allowing them to supply Samsung Bioepis’ Renflexis to the US Department …
Samsung Bioepis – the collaboration between Samsung Biologics and Biogen Idec, has become the first company to have a biosimilar …

A pilot programme for Apple’s mobile health platform HealthKit has been rolled out across a number of US hospitals to …

Any firms making exaggerated health claims of wearable devices face marketplace disappointment following new FDA guidelines. The FDA has released …
Plans to improve the quality of patient care by introducing a ‘kitemark’ to safely validate healthcare apps have been announced …

General practitioners in the UK are to begin ‘prescribing’ health apps as part of a move to better monitor issues …

The interest in mobile health (mHealth) wearables is gaining traction, but consumers want more affordable devices that offer greater engagement …

Apple’s new mobile software iOS8 was launched around the world yesterday but the eagerly anticipated centrepiece HealthKit app was conspicuous …

Apple has finally unveiled its long-rumoured ‘smartwatch’ to the world along with new iPhones and a payment system. At the …

Google is to launch a health platform to rival Samsung’s SAMI offering and Apple’s HealthKit into an ever-expanding technology marketplace. …

Apple has followed Samsung into the e-health arena by unveiling HealthKit, a new platform that allows users to pool their …

Samsung has taken another step towards realising the potential of wearable health tech with the launch of a new ‘smart’ …